[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Dorjbal et al., 2018 - Google Patents

Hypomorphic CARD11 mutations associated with diverse immunologic phenotypes with or without atopic disease

Dorjbal et al., 2018

View HTML
Document ID
1259763876645542578
Author
Dorjbal B
Stinson J
Ma C
Weinreich M
Miraghazadeh B
Hartberger J
Frey-Jakobs S
Weidinger S
Moebus L
Franke A
Schäffer A
Bulashevska A
Fuchs S
Ehl S
Limaye S
Arkwright P
Briggs T
Langley C
Bethune C
Whyte A
Alachkar H
Nejentsev S
DiMaggio T
Nelson C
Stone K
Nason M
Brittain E
Oler A
Veltri D
Leahy T
Conlon N
Poli M
Borzutzky A
Cohen J
Davis J
Lambert M
Romberg N
Sullivan K
Paris K
Freeman A
Lucas L
Chandrakasan S
Savic S
Hambleton S
Patel S
Jordan M
Theos A
Lebensburger J
Atkinson T
Torgerson T
Chinn I
Milner J
Grimbacher B
Cook M
Snow A
Publication year
Publication venue
The Journal of allergy and clinical immunology

External Links

Snippet

Background CARD11 encodes a scaffold protein in lymphocytes that links antigen receptor engagement with downstream signaling to NF-κB, JNK, and mTORC1. Germline CARD11 mutations cause several distinct primary immune disorders in humans, including SCID …
Continue reading at pmc.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/18—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for functional genomics or proteomics, e.g. genotype-phenotype associations, linkage disequilibrium, population genetics, binding site identification, mutagenesis, genotyping or genome annotation, protein-protein interactions or protein-nucleic acid interactions
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms

Similar Documents

Publication Publication Date Title
Dorjbal et al. Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease
Yin et al. Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2
Salas et al. Enhanced cell deconvolution of peripheral blood using DNA methylation for high-resolution immune profiling
Fonseka et al. Mixed-effects association of single cells identifies an expanded effector CD4+ T cell subset in rheumatoid arthritis
Mighell et al. A saturation mutagenesis approach to understanding PTEN lipid phosphatase activity and genotype-phenotype relationships
Gondek et al. Assessing clonal haematopoiesis: clinical burdens and benefits of diagnosing myelodysplastic syndrome precursor states
Chen et al. DNA methylation-based measures of biological age: meta-analysis predicting time to death
da Silva Almeida et al. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome
Neeland et al. Mass cytometry reveals cellular fingerprint associated with IgE+ peanut tolerance and allergy in early life
Gresele et al. Inherited platelet function disorders: algorithms for phenotypic and genetic investigation
Ferraro et al. Interindividual variation in human T regulatory cells
Chang et al. A molecular signature of preclinical rheumatoid arthritis triggered by dysregulated PTPN22
Bunis et al. Single-cell mapping of progressive fetal-to-adult transition in human naive T cells
Chen et al. A road map from single-cell transcriptome to patient classification for the immune response to trauma
US20170184594A1 (en) Pathway characterization of cells
Carreras et al. Artificial intelligence analysis of gene expression data predicted the prognosis of patients with diffuse large B-cell lymphoma
Fattizzo et al. Hypoplastic myelodysplastic syndromes: just an overlap syndrome?
Throm et al. Dysregulated NK cell PLCγ2 signaling and activity in juvenile dermatomyositis
Imran et al. Epigenetic programming underpins B‐cell dysfunction in peanut and multi‐food allergy
Van Unen et al. Identification of a disease-associated network of intestinal immune cells in treatment-naive inflammatory bowel disease
Lampson et al. Rare germline ATM variants influence the development of chronic lymphocytic leukemia
Baysac et al. PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variants
Gao et al. Protein biomarkers in monocytes and CD4+ Lymphocytes for predicting lithium treatment response of bipolar disorder: A feasibility study with tyramine-based signal-amplified flow cytometry
Dorjbal et al. Hypomorphic CARD11 mutations associated with diverse immunologic phenotypes with or without atopic disease
Li et al. Role of ferroptosis-associated genes in ankylosing spondylitis and immune cell infiltration